“I want to make sure Boost vaccines are available in the fall so we can protect people when we go into the next fall and winter seasons in the US,” Bancel said in an interview on “Squawk Box.”
Last month, the National Institutes of Health started testing a variety of offers from Moderna to being used as a third shot to improve immunity protection as concerns about emerging variants grow – including the variant first discovered in South Africa, also known as the B.1.351 variant.
The Food and Drug Administration’s approach to approving modified Covid vaccines is: similar to annual flu vaccinesThis means they could be released for emergency use without lengthy clinical trials.
Massachusetts-based Moderna hopes to submit data to regulators within months, Bancel added. “Our goal is to work really hard to get this ready before the fall,” he repeated.
Bancel’s comments came a day after Moderna announced it was a vaccine more than 90% effective for protection against Covid up to six months after the second dose. It was more than 95% effective against serious illnesses over the same period, the biotech company said in its update, which could bring it closer to full regulatory approval.
Currently there are 453 reported cases Participation of variant B.1.351 according to information from the Centers for Disease Control and Prevention. This variant has particularly affected public health experts. It was shown reduce the effectiveness of existing Covid vaccines, including by Moderna.
Bancel on Wednesday reiterated his belief that annual Covid vaccine boosters will be the order of the day in the future, saying the coronavirus is “not going away” and “not leaving the planet”.
“I expect we’ll see a lot of variants in the next year. However, as more people get vaccinated or infected naturally, the pace of the variant will slow down and the virus will stabilize like you see with the flu,” said Bancel.
Finally, he added, Moderna is hoping to have some sort of two-in-one vaccine that will protect against seasonal flu and Covid. The Company in September announced its intention to manufacture a flu vaccine.
“What we’re actually trying to do at Moderna is to get a flu vaccine at the clinic this year and then combine our flu vaccine with our Covid vaccine so all you have to do is get a boost at your local CVS store … every year, that would protect you from the variant of concerns about Covid and the seasonal strain of flu, “Bancel said.
“We believe we can get a highly effective flu vaccine,” he added. Current flu vaccines are roughly between 40% and 60% effective every year. according to CDC.
Bancel also weighed on US regulators We recommend Tuesday that states pause with Johnson & Johnson’s single-shot Covid vaccine After a concern, rare but severe blood clots developed in the recipients.
The move shows “that the FDA will not hesitate to be very careful to analyze the data, take the time necessary to do so and protect the safety of the American people,” he said, arguing that the way How regulators handle the J&J situation would decrease the vaccine hesitation, not increase it.